The Cooper Companies, Inc. (NASDAQ:COO) Shares Sold by Vestmark Advisory Solutions Inc.

Vestmark Advisory Solutions Inc. reduced its stake in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 6.6% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 61,954 shares of the medical device company’s stock after selling 4,383 shares during the quarter. Vestmark Advisory Solutions Inc.’s holdings in Cooper Companies were worth $5,695,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also recently bought and sold shares of COO. Victory Capital Management Inc. increased its holdings in Cooper Companies by 23.0% during the 3rd quarter. Victory Capital Management Inc. now owns 3,950,119 shares of the medical device company’s stock valued at $435,856,000 after acquiring an additional 737,726 shares in the last quarter. Raymond James Financial Inc. purchased a new position in shares of Cooper Companies during the 4th quarter worth approximately $64,826,000. JPMorgan Chase & Co. raised its position in shares of Cooper Companies by 13.2% during the 3rd quarter. JPMorgan Chase & Co. now owns 4,930,022 shares of the medical device company’s stock worth $543,979,000 after purchasing an additional 573,908 shares during the last quarter. Alecta Tjanstepension Omsesidigt acquired a new stake in Cooper Companies during the 4th quarter valued at $49,550,000. Finally, Swedbank AB increased its position in Cooper Companies by 14.0% during the fourth quarter. Swedbank AB now owns 1,629,602 shares of the medical device company’s stock worth $149,809,000 after buying an additional 200,000 shares in the last quarter. 24.39% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

COO has been the subject of several analyst reports. Morgan Stanley cut their price target on Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating for the company in a report on Friday, December 6th. StockNews.com lowered Cooper Companies from a “buy” rating to a “hold” rating in a research note on Wednesday, December 11th. Citigroup decreased their target price on Cooper Companies from $116.00 to $115.00 and set a “buy” rating for the company in a research note on Friday, December 6th. Needham & Company LLC restated a “hold” rating on shares of Cooper Companies in a research report on Friday, December 6th. Finally, Wells Fargo & Company increased their price target on shares of Cooper Companies from $115.00 to $118.00 and gave the stock an “overweight” rating in a research report on Friday, December 6th. Three analysts have rated the stock with a hold rating and eight have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $117.22.

Cooper Companies Stock Performance

Shares of COO stock opened at $91.33 on Thursday. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.12 and a current ratio of 1.91. The firm has a market cap of $18.23 billion, a price-to-earnings ratio of 46.84, a P/E/G ratio of 2.25 and a beta of 1.02. The Cooper Companies, Inc. has a 52 week low of $84.76 and a 52 week high of $112.38. The firm’s 50-day simple moving average is $92.56 and its two-hundred day simple moving average is $99.51.

Cooper Companies (NASDAQ:COO) last posted its quarterly earnings results on Thursday, December 5th. The medical device company reported $1.04 EPS for the quarter, topping analysts’ consensus estimates of $1.00 by $0.04. The firm had revenue of $1.02 billion during the quarter, compared to analyst estimates of $1.03 billion. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The business’s revenue for the quarter was up 9.8% on a year-over-year basis. During the same period last year, the company earned $0.87 earnings per share. As a group, equities analysts forecast that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.